USFDA conducting inspection of Mohali plant: Sun PharmaThe inspection by the United States Food and Drug Administration (USFDA) started on September 10, 2018 and is ongoing, Sun Pharma said in a...
11 Sep, 2018, 09.24 PM IST
Godrej Appliances to invest Rs 200 crore in Shirwal plant"The proposed expansion, once complete, will allow us to meet the increasing demand of premium products from Indian customers and expand ou...
22 Nov, 2017, 06.55 PM IST
Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unitThe Mohali facility was inherited by Sun Pharma as part of its acquisition of Ranbaxy Laboratories in 2015.
15 Mar, 2017, 12.05 AM IST
Ranbaxy's hunt for FDA-okayed plants in India pushes stock higherRanbaxy is looking at FDI-okayed plants in an attempt to reduce risks arising out of issues with its Mohali plant, said two persons familia...
07 Oct, 2013, 09.59 AM IST
Ranbaxy hunts for FDA-okayed plants in IndiaThis move will ensure launch plans are not jeopardised following Mohali setback.
07 Oct, 2013, 05.40 AM IST
Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDaiichi Sankyo will work with US authorities to resolve issue of a ban imposed by USFDA on import of drugs from Mohali plant of Ranbaxy.
24 Sep, 2013, 04.06 PM IST
UK, Australia regulators seek details of US findings on Ranbaxy’s Mohali plantA spokesperson from UK drug regulator told ET that the agency is in touch with the US FDA to assess how this ban would affect Ranbaxy drugs...
23 Sep, 2013, 04.28 AM IST
Ranbaxy seeks to assuage shareholders' worries after USFDA banRanbaxy Laboratories today sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock.
21 Sep, 2013, 09.19 AM IST
Certain consent decree terms to apply to Mohali unit: RanbaxyThe decree contains provisions to ensure CGMP (Current Good Manufacturing Practices) compliance at certain Ranbaxy facilities.
17 Sep, 2013, 05.20 PM IST
USFDA import ban on Ranbaxy's Mohali plant to hit future launchesWith the problems with the USFDA showing no signs of abating, investors are unlikely to repose confidence in the stock any time soon.
17 Sep, 2013, 08.52 AM IST
Ranbaxy dives over 30%; m-cap down by Rs 5,855 crore on USFDA import alertA massive sell-off in the stock sent the company's market value down by Rs 5,855 crore to Rs 13,491 crore.
16 Sep, 2013, 05.47 PM IST
Ranbaxy Laboratories ends 30% lower on USFDA import alert for Mohali plantRanbaxy Laboratories plunged 35% on Monday on reports that USFDA has issued an import alert for drugs manufactured at its plant in Mohali.
16 Sep, 2013, 04.32 PM IST
Ranbaxy hits 52-week low on USFDA query on Mohali plantThe stock has plunged over 10 per cent so far in the month of June and has lost more than one-fourth of its value so far in the year 2013.
24 Jun, 2013, 10.18 AM IST
- Ranbaxy Laboratories shifts production of Lipitor generic to Mohali
Ranbaxy Laboratories has started shifting production of its generic version of the world's bestselling drug Lipitor from the US to its new ...
13 Aug, 2012, 05.50 AM IST
- USFDA inspects Ranbaxy's new plant in Mohali
The USFDA did not respond to an e-mail query. The company's share price closed at 515.05, down 2.95% at the Bombay Stock Exchange on Wednes...
24 Jun, 2011, 03.31 AM IST
- Ranbaxy may wind up Mohali unit
The company sources products from local units now; may outsource manufacturing.
18 Jun, 2010, 03.56 AM IST
- Ranbaxy seeks to sell drugs from new Mohali plant in US
Ranbaxy Laboratories has filed for US Food and Drug Administration's (USFDA) approval to sell medicines from its upcoming manufacturing uni...
02 Aug, 2008, 12.01 AM IST